Schwab Andrew J.

SEC Form 4 insider
Skye Bioscience, Inc. ($SKYE), Camp4 Therapeutics Corp ($CAMP)
1 thesis · first seen Aug 20, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d000———
3d111100%-3.6%-3.6%
1w111100%-7.4%-7.4%
1m111100%-5.4%-5.4%
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$CAMPSEC Form 4bearish
Schwab Andrew J. · Camp4 Therapeutics Corp · 60d agono track record yet
Sold 191,865 @ $4.59 avg · $879,719 · 2026-08-19

Form 4: Schwab Andrew J. sold CAMP

Schwab Andrew J. (Director at Camp4 Therapeutics Corp) reported an open-market sale of 191,865 shares of CAMP at an average $4.59, roughly $879,719, in a Form 4 filed 2026-08-21.

At post $4.48Now $4.32-3.6% since postedas of Aug 24, 1:28 PM ET
1d—
3d-3.6%
1w-7.4%
1m-5.4%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.